(15128), J. L., (2363809), L. W., (594653), Z. L., (9021539), S. S., (359834), J. L., (501522), Z. G., . . . (780252), X. M. (2021). Table_1_18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment.docx.
Chicago Style (17th ed.) Citation(15128), Jie Liu, Leilei Wu (2363809), Zhiguo Liu (594653), Samuel Seery (9021539), Jianing Li (359834), Zhenhua Gao (501522), Jinming Yu (652099), and Xue Meng (780252). Table_1_18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment.docx. 2021.
MLA (9th ed.) Citation(15128), Jie Liu, et al. Table_1_18F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment.docx. 2021.